Participantes
DIRECCIÓN
Ana Clopés
Director of Assistance at the Catalan Institute of Health and
Director of Medicine Policy at the Catalan Institute of Oncology
Francisco Zaragozá
Professor of Pharmacology at the Alcalá de Henares University
SECRETARÍA
Borja Smith
Partner and Pharma
Bio Director at SILO - Science and Innovation Link Office
PARTICIPANTES
Jesús Acebillo
President of Novartis Group Spain
Antonio Arraiza Armendáriz
Director of Medical Assistance in Osakidetza (Basque Health System)
María Isabel Baena
General Director of Research and Knowledge Management at the Regional Ministry of Health in Andalusia
Birgit Beger
CEO European Cancer Organization (ECCO)
Beatriz Bernárdez
Oncology Pharmacist in the University Hospital Complex of Santiago de Compostela
Josep María Borrás
Director of the Oncology Plan of Catalonia, Coordinator of the Executive Commission of Cancer Collaborative Research Network and Scientific Coordinator of the Cancer Strategy of the National Health System
Candela Calle
Director of the Catalan Institute of Oncology (ICO)
Director of the Catalan Institute of Health (ICS)
José Ignacio Echániz
Partido Popular Member of Parliament representing Madrid
Jaime Espín Balbino
Professor at the Andalusian School of Public Health and member of the Expert Committee on Drug Policy of the Pan American Health Organization (PAHO / WHO) and member of the Pricing Policy of the WHO Project on Medicine Price and Availability
Joseph A. Fraietta
Associate Director of the Process/Product Development Laboratory (PDL) in the Center for Advanced Cellular Therapeutics in the Perelman Center for Advanced Medicine Pennsylvania
Gabriel Galván
Novartis Oncology General Manager Spain
Cristina Garmendia
Former Minister of Science and Innovation
President of COTEC Foundation
Cristina Granados
Managing Director at the University Hospital of Salamanca
Rodrigo Gutiérrez
Managing Director of Quality and Humanization of Healthcare in
Castilla La Mancha Health Service (SESCAM)
Francisco Igea
Cuidadanos Member of Parliament representing Valladolid
María Jesús Lamas
Director of the Pharmacy Service of the University Hospital Complex of Santiago de Compostela and Research Director of the Spanish Society of Hospital Pharmacy (SEFH)
Guillem López-Casasnovas
Professor of Economics at the University Pompeu Fabra of Barcelona
Former President of the International Health Economics Association
Rafael López
Director of the Oncology Service of the University Hospital Complex of Santiago de Compostela
José Martínez Olmos
Spanish Socialist Party (PSOE) Member of Parliament representing Granada
Marta Moreno
Market Access & Public Affairs
Head Novartis Oncology
María Dolores Navarro Rubio
Head of the Epidemiology and Public Health Department at the Faculty of Medicine and Health Sciences in the University of Catalonia
César Nombela
Rector of the Menéndez Pelayo International University and
Professor of Microbiology at the Faculty of Pharmacy in the Complutense University or Madrid
María Ochoa de Olza
Clinical Researcher at Vall d'Hebrón University Hospital
Miguel Ángel Piris
Director of the Pathology Service of the University Hospital Marqués de Valdecilla and Scientific Director of the IFIMAV Santander
María Luisa Poncela García
General Secretary of Science and Innovation at the National Ministry of Economy and Competitiveness
Daniel Rodríguez González
Director of 6W Communication
Jordi Sierra
Director of Clinical Hematology Service
Santa Creu i Sant Pau Hospital
Elected president of the Spanish Society of Hematology and Hemotherapy (SEHH)
Bruno Strigini
CEO Novartis Oncology
Programa
Jueves, 15 Septiembre 2016
11:00
Welcome
César Nombela
Francisco Zaragozá
Ana Clopés
Gabriel Galván
11:30
Inaugural Conference
Novartis Oncology: transforming cancer care
Bruno Strigini
11:50
Scientific Act (part 1)
Targeted therapy driven by molecular diagnosis
Miguel Ángel Piris
How to design new clinical trials in the era of precision medicine and immuno-oncology
María Ochoa de Olza
CART T cells
Joseph A. Fraietta
Moderación: Francisco Zaragozá
15:30
Scientific Act (part 2)
Reseach and innovation in Oncology
María Isabel Baena
The role of University hospitals in traslational research
Cristina Granados
Ana Clopés
17:15
Debate between the four main political parties:
"Where are we going in health and pharmaceutical in Spain?"
José Martínez Olmos
José Ignacio Echániz
Francisco Igea
Daniel Rodríguez González
Viernes, 16 Septiembre 2016
09:00
Access to onco-hematological Innovation / Health Economics
Cancer strategies
Josep María Borrás
Managing onco-hematology medical assistance and access to innovation in Osakidetza
Antonio Arraiza Armendáriz
The clinical before the onco-hematological process
Rafael López
Hematology access to innovation
Jordi Sierra
The pharmacist as a necessary partner for patient care
María Jesús Lamas
Candela Calle
11:00
Humanization in Onco-hematology
Rodrigo Gutiérrez
Consultation of pharmaceutical care for the onco-hematological patient
Beatriz Bernárdez
Patient empowerment in Oncology
Birgit Beger
María Dolores Navarro Rubio
12:30
Debate: Trends in Pharmaco-economics in the world:
theoretical and empirical evidence
Jaime Espín Balbino
Guillem López-Casasnovas
Moderación: Marta Moreno
13:35
Innovation from a broader vision
Cristina Garmendia
13:50
Closing
César Nombela
Francisco Zaragozá
Ana Clopés
Jesús Acebillo
María Luisa Poncela García
